← Back to All Filings

Erie Indemnity Director Receives Deferred Stock Grant

Low SignificanceNovember 3, 2025 at 3:02:00 PM EST

ERIE INDEMNITY CO

$ERIE4CIK: 0000922621

Subscribe to track ERIE

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Erie Indemnity Director Receives Deferred Stock Grant

Company: ERIE INDEMNITY CO (ERIE) Form: 4 | Filed: 2025-11-03 Significance: Low

Insider: Hudson Brian Arden Sr. Title: Director | Relationship: Director

Transaction: • Type: Grant (Deferred Comp) • Shares: 39.474 • Price: $292.64 • Value: $11,553 • Owned After: 3,249 (Share Credits)

Key Insight: A routine acquisition of deferred stock units by a director as part of their compensation plan, representing a negligible fraction of the company's market cap.

Market Context: The transaction is immaterial against Erie's $15.30 billion market capitalization and has no significant market impact.

Comprehensive Analysis

SEC Filing Analysis: ERIE INDEMNITY CO (ERIE)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director received a small, routine grant of deferred stock units as part of their compensation, with no meaningful market impact.
  • Market Impact: Neutral. The transaction is too small to influence market sentiment or trading volume.

Company Information

FieldValue
CompanyERIE INDEMNITY CO
Ticker SymbolERIE
CIK0000922621
IndustryINSURANCE AGENTS BROKERS & SERVICES

Insider Information

FieldValue
NameHudson Brian Arden Sr.
CIK0001705005
Title/Positionnull
RelationshipDirector

Transaction Details

FieldValue
Form Type4
Transaction Date2025-10-31
Transaction CodeJ (Other acquisition)
Security TypeDirectors' Deferred Compensation Share Credits
Shares Involved39.474
Price Per Share$292.64
Total Value$11,553.06
Shares Owned After3248.955 (Derivative Securities)
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$11,553.06
% of Market Cap<0.0001%
Shares Transacted39.474
% of Shares Outstanding<0.0001%
Post-Transaction Ownership3,248.955 derivative shares (0.007% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The transaction value of approximately $11.5k is negligible for a company with a market capitalization of $15.30 billion.
  • Ownership Concentration: The director's total derivative holdings remain a very small fraction of the company's total shares outstanding, indicating low ownership concentration from this individual.
  • Dilution Impact: The grant of ~39 share equivalents has a virtually zero dilutive effect on the 46.2 million shares outstanding.
  • Transaction Significance: This is a routine, non-discretionary transaction related to director compensation and does not provide any new insight into the insider's view of the company's future prospects.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is a standard compensation grant, not an open-market purchase. Its size is immaterial relative to the company's market cap and daily trading volume.

Volume & Sentiment

  • Expected Volume Impact: None. The transaction is too small to affect trading volume.
  • Sentiment Indicator: Neutral. This type of filing is common and does not typically influence investor sentiment.

Additional Context

Transaction Notes

  • Special Circumstances: The transaction involves the acquisition of 'Share Credits' under the Outside Directors' Deferred Compensation Plan. These credits represent the right to receive an equivalent number of Class A common stock shares upon the termination of the director's service. They are not immediately tradable.
Topics:#SECFiling#InsiderTrading#ERIE#Form4#StockGrant#ErieIndemnity#Investing#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.